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Abstract 
The clinical impact of risk factors and 
vasodilator therapy in prevention of acute 
ischemic stroke remains uncertain. Ischemic 
stroke was considered severe in the 
Romanian Stroke Prevention Society. Poor 
outcome are at 10 days after onset of a minor 
ischaemic stroke or a transient ischaemic 
attack. The association between predictors 
and outcome was assessed using 
unconditional multivariable logistic 
regression. Covariates used included age, 
stroke severity, diabetes mellitus, coronary 
artery disease, atrial fibrillation, premorbid 
hypertension and hyper-lipidemia and the 
results pursuited by Transcranial Doppler, 
analyzing the Pendefunda’s Index. Three 
hundred and twenty-eight patients were 
included. Compared to patients predicted as 
normal who were found to have an 
increased stroke risk, our patients decreasd 
the clinical aspects after the vasodilators 
administration, while the reactivity in the 
first week after stroke onset was found to 
result in a decreased risk. However, neither 
of these findings remained significant after 
adjustment for the described covariates if we 
haven’t test the best reactivity to the drugs. 
Keywords: acute ischemic stroke, brain 
infarction, clinical management of stroke, 
prediction of outcome, stroke prognosis, 
transient ischaemic attack, minor ischaemic 
stroke 
Introduction 
Transcranial Doppler sonography 
(TCD) is used to assess cerebral blood flow 
velocity in basal cerebral arteries and is a 
common tool for the diagnosis and follow-
up of cerebrovascular disease. With more 
than hundred clinical studies using TCD 
published annually, indications for its use 
are expanding. The clinical applications for 
TCD including delayed vasospasm after 
subarachnoid hemorrhage, sickle cell 
disease, atherosclerosis of cranial vessels, 
ischemic stroke, brain trauma, brain death, 
carotid artery disease, cerebral venous 
thrombosis, intraoperative TCD 
monitoring, arteriovenous malformations, 
cardiac shunts and preeclampsia, the 
reactivity after vasodilators of the cerebral 
arteries. The relevance of acute changes in 
blood pressure and the impact of 
vasodilator therapy administered in the 
acute period are also uncertain. There is 
currently little data from randomized 
controlled trials to inform physicians about 
the management of blood pressure and its 
relation to patient outcome in acute 
ischemic stroke. Most studies assessing the 
impact of the risk factors in the acute period 
have focused on functional outcomes after a 
minor ischaemic stroke or a  Transient 
ischaemic attack. Recent clinical studies 
have suggested that more than 75% of acute 
ischemic stroke patients present have 
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hypertension. However, despite this high 
prevalence, our understanding of the 
potential impact of the level of blood 
pressure in acute stroke remains 
incomplete. Several authors argue that 
elevated post-stroke blood pressure leads to 
poor outcome, related to increased cerebral 
edema and risk of hemorrhagic 
transformation. Alternatively, other reports 
emphasize a relationship between low 
blood pressure and poor outcome, citing 
threats to the ischemic penumbra. 
Prevention of a severe ischaemic stroke is 
our goal of this present study.  
Methods 
We reviewed the records of all patients 
presenting with transient ischemic attack or 
a minor ichaemic stroke more two days 
after symptom onset and in-hospital stroke 
secondary to a surgical or major medical 
event(s).  
TCD was first used in 1981 when Aaslid 
and coworkers assessed middle cerebral 
artery cerebral blood flow velocity in 
patients with aneurysmal subarachnoid 
hemorrhage indicating vasospasm. The 
main difference between Aaslid’s “Ur-
Doppler” and other, conventional Doppler 
ultrasound devices at the time was that the 
bidirectional probe was pulsed with a lower 
frequency of 2 MHz in order to sufficiently 
penetrate the temporal bone window. Its 
main advantages compared to most other 
neuroimaging methods are convenience, 
mobility, low cost, non-invasiveness, and 
lack of side-effects. The TCD technique is 
noninvasive and can easily be repeated 
bedside without any risk for the patient. 
The agility of the TCD equipment has also 
raised hopes for ultra early assessment of 
intracranial dynamics following head 
injury. However, the results of a TCD 
examination depend on the experience and 
diligence of the examiner.  Clinicians need 
to follow these developments but should 
also beware of their often somewhat limited 
practical value. To assess the usefulness of 
TCD, it is impracticable or simply not 
applicable to perform blinded, randomized 
or placebo-controlled studies. Yet, guidance 
for using TCD should be obtained from 
prospective studies with sufficiently large 
patient samples and with a reasonably 
simple and reproducible technique. Our 
studies fulfilling the criteria of broad study 
population, validation of TCD by 
comparison to the other researches, blinded 
evaluation of the data and statistically 
dependable diagnostic or prognostic value.  
The value of TCD recordings in patients 
with head injury is, however, controversial 
even though changes in flow velocities may 
enable early detection of potentially 
treatable cerebral blood flow disturbances. 
We introduced new methods in our clinic 
in 1987 and than developed them in 
Freiburg between the years 1988-89, 
introducing new indices for the evaluation 
of the cerebral blood flow. One investigator 
conducted all TCD examinations. 
The daily TCD measurements were 
conducted transtemporally using a 
traditional 2-MHz transducer (EME TC-64 
Eden medical records, Uberlingen, 
Germany). The TCD measurements were 
routinely performed bilaterally on the 
middle cerebral artery and verebro basilar 
arteries. Recordings were pursuited 
analyzing the Gosling’s Pulsatility Index 
(PI) calculated according to the method of 
Gosling derived from the difference in the 
systolic and diastolic flow velocity. Than 
the PI data were correlated to the results 
after vasodilators administration related to 
the Pendefunda’s Reactivity Index (RI) 
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described in 1988. There are more than 
twenty years that this index, which I 
described, was used, because I considered 
necessary an easyar evaluation of the 
vascular replay to a drug administration. 
Technique 
In addition to the medical indication to 
perform TCD, subjects need a sufficiently 
thin temporal bone window to enable 
penetration of the 2 MHz waves. The 
temporal window is suitable for insonation 
in more than 90% of patients, but may 
become more difficult to penetrate in older 
patients, which prompted the development 
of a 1 MHz probe. TCD permits evaluation 
of the MCA, anterior cerebral artery 
(ACA), posterior cerebral artery (PCA) and 
terminal internal carotid artery (ICA). The 
suboccipital (transforaminal) insonation can 
be performed on a supine or sitting patient 
and yields good accessibility of the basilar 
artery (BA) and possibly the vertebral 
arteries (VA). A transorbital approach can 
be used to insonate the ICA in the carotid 
siphon and the ophthalmic artery. Unless 
stated otherwise, cerebral blood flow 
indicates mean flow velocity. Ample 
reference values for it, proper angle and 
depth of insonation are provided for 
healthy subjects, including stratifications for 
age and sex. Cerebral blood flow obtained 
by TCD devices is a result of a spectrum of 
waves reflected by erythrocytes, and thus 
depends particularly on hematorheological 
conditions. In patients with very low 
hematocrit (under 30%), the velocity is 
increased due to a decrease in viscosity. 
Thus, TCD interpretation in patients with 
abnormal blood viscosity requires 
caution. An insonation of all accessible 
arteries can help distinguish between a 
systemic cause of increased velocity (fever, 
hematocrit) or a focal increase suggesting a 
local abnormality. Moreover, sufficient 
time to perform a thorough examination 
and experience are key factors contributing 
to its accuracy. 
Patients were categorized into those who 
continued to receive antihypertensives for 
more than five days out after the transient 
ischaemic attack or minor ischaemic stroke 
onset versus those who did not. Patients 
received AHT as per the clinical judgment 
of the treating neurology team. 
Antihypertensive medications included: a-
adrenergic receptor blockers, angiotensin-
converting enzyme inhibitors, angiotensin 
receptor blockers, (3-adrenergic receptor 
blockers, calcium antagonists, diuretics, 
centrally acting agents (including a-
methyldopa and clonidine), nitric oxide 
donors, Cerebrolysin or Actovegin.  
Comorbidities, including history of 
coronary artery disease, atrial fibrillation, 
substantial carotid stenosis, chronic 
hypertension, diabetes mellitus, and 
hyperlipidemia were recorded using patient 
histories as documented by the neurology 
team. In the case of hypertension, diabetes 
mellitus and hyperlipidemia, premorbid 
and hospital discharge use of disease-
modifying therapy was also used in defining 
these conditions. Atrial fibrillation was 
defined as any evidence of atrial fibrillation 
on history or by electrocardiography. 
Substantial carotid stenosis was defined as 
more than 50% narrowing of one or more 
extracranial vessels as docu-mented by 
carotid Doppler. 
Results 
With repeated carotid Doppler 
sonograms, Steiger investigated PI in 
patients with severe head injury as 
compared to healthy volunteers. This 
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extracranial utilization of PI revealed values 
between 1.5 to 2.0 in control subjects with a 
gradual increase in cases with posttraumatic 
brain edema. PI values were associated with 
severe intracranial hypertension, and in 
cases of angiographically demonstrated 
cerebral circulatory arrest, PI values in the 
range of 6 to 8 were found. RI was present 
in a significant correlation between PI and 
the risk factors we found. 
The correlation are stronger as 
compared to previous studies. Homburg 
investigated 10 head injured patients and 
demonstrated a positive exponential 
correlation between PI and the blood 
pressure. McQuire and colleagues 
performed TCD measurements within 3 
hours after injury on 22 head injured 
patients. Moreno correlated TCD 
measurements and found that an elevated 
PI predicts poor outcome, and furthermore, 
we sow a good reactivity in the larger 
arteries but different between the same in 
wright or left side, different for the same 
drug to each patient, more after a minor 
stroke or a transient ischaemic attack. These 
findings strongly suggest the presence of 
high distal vascular resistance in the early 
phase after head injury. The authors also 
showed that one-third of patients with 
severe head injuries have vasospasm, and 
that vasospasm will significantly change 
both PI and RI. In our study we found that 
RI reflectes the best drug we may 
administrate to a patient, different from one 
to another and the poor reactivity in the 
case of a reduced volume flow in the 
insonated artery, and can hence be helpful 
to indicate compromised cerebral 
perfusion. This aspect should guide the 
choice of a medication able to prevent a 
new attack. The differences between the 
drugs we presented in a lot studies in these 
twenty four years. 
Our results demonstrate that RI may be 
influenced by different factors, like 
hemodynamic, respiratory, and hematologic 
parameters, and, in the case of brain vessels, 
tissue compliance. For this reason, the 
absolute value of this index is, in general, 
not considered sufficient to characterize 
overall intracranial hemodynamic 
conditions if no other information is 
simultaneously provided. The main 
advantage of RI is that, being a ratio, it is 
not affected by the pressure created by the 
heart, but in the arterioles the normal mean 
pressure drops. During elevated intracranial 
pressure, the arterioles are easily 
compressed creating a high peripheral 
vascular resistance reducing the flow, and 
thereby, the denominator of the PI after 
and before the administration of the drug. 
The numerator of the PI derives from the 
difference between systolic and diastolic 
flow velocities. The elasticity of the normal 
vascular system dampens the flow and flow 
velocity fluctuations because of blood 
pressure changes, which is in contrast to a 
rigid tube where the pressure is directly 
proportional to the flow velocity. A clinical 
setting where this is apparent is the 
elevation of PI in diabetic patients with 
cerebral microangiopathy and hence 
depressed vessel compliance. An increased 
intracranial pressure always results in 
reduced compliance of the entire brain 
tissue including increased rigidity of the 
brain arteries augmenting the velocity 
variations, which in turn increases the PI. 
Consequently, the great difference between 
two TCD measurements (a major RI) 
reflects the changes in the perpheric 
resistence and the benefices of the 
vasodilator used. The flow velocity pattern 
in cerebral arteries is affected both by 
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cerebrospinal fluid pulsatility and the 
reactivity of cerebrovascular control 
mechanisms. The different risk factors 
pursuited by us showed that atherosclerosis 
was the worst for the prognostic because 
the reactivity of a such an artery is 
practically zero. 
Discussion 
In the present study, we observed a 
relationship between initial PI and early 
functional outcome and survival as 
determined at two weeks after ischemic 
stroke onset. Poorest outcome was among 
those with a low RI. This finding remained 
valid when analyzed in a continuous 
quadratic model. In addition, these results 
remained significant after adjustment for 
multiple covariates including age, initial 
stroke severity, premorbid history of 
hypertension, hyperlipidemia, diabetes 
mellitus, coronary artery disease, atrial 
fibrillation and substantial carotid stenosis. 
Other previous studies have 
demonstrated similar relationships. Some 
authors have suggested that levels of blood 
pressure in the acute post-stroke period 
increase with initial stroke severity in a 
compensatory fashion to ensure perfusion 
of the ischemic territory and that 
Pendefunda’s Index suggest a better 
medication. These authors conclude that 
the relationship between elevated blood 
pressure and poor outcome is not a causal 
one. This would suggest that the initial 
level does have an effect on short-term 
outcome that appears to be independent of 
the initial stroke severity. 
The our study the elevations of RI more 
than 15% in the first 24 h may assure good 
results. On the other hand, some authors 
have reported that substantial decreases in 
early blood preasure levels can also be 
strong predictors of poor outcome. These 
findings, at first contradictory, would be 
consistent with the rationale that, while 
moderate decreases in levels of blood 
pressure are protective against hemorrhagic 
transformation and cerebral edema, 
excessive acute decreases may threaten the 
ischemic penumbra. This interpretation is 
consistent and we emphasize a limited and 
gradual increase in the RI in the acute 
period. However, our findings may suggest 
that equally important recommendations 
should be made to search the best 
vasodilator after the attack in order to have 
good results in careing and preventing a 
major stroke. 
Conclusion 
Our datas show a highly significant 
correlation between the increased rate of 
risk factors for the early outcome of an 
ischaemic head injury and the pursuit of the 
RI to prevent a major stroke. Compared to 
patients predicted as normal who were 
found to have an increased stroke risk, our 
patients decreasd the clinical aspects after 
the vasodilators administration, while the 
reactivity in the first week after stroke onset 
was found to result in a decreased risk. 
However, neither of these findings 
remained significant after adjustment for 
the described covariates if we haven’t test 
the best reactivity to the drugs. 
References 
1.  Aaslid R, Markwalder T-M, Nornes H. Noninvasive 
transcranial Doppler ultrasound recording of flow 
velocity in basal cerebral arteries. J Neurosurg 1982;57: 
769–74. 
2. Aaslid R, Huber P, Nornes H. Evaluation of 
cerebrovascular spasm with transcranial Doppler 
ultrasound. J Neurosurg 1984;60:37–41. 
3. Aaslid R. Transcranial Doppler Software 
(http://www.transcranial.com), last access: 09/20/2006 
 
 
 
36          L. Pendefunda          Transcranial Doppler and vasodilators therapy 
 
 
 
4. Aaslid R. Cerebral Autoregulation and Vasomotor 
Reactivity. In: Baumgartner RW, editor. Handbook on 
Neurovascular Ultrasound Front Neurol Neurosci 
Basel 2006; 216-28. 
5. Ackerstaff RG, Keunen RW, van Pelt W, Montauban 
van Swijndregt AD, Stijnen T. Influence of biological 
factors on changes in mean cerebral blood flow velocity 
in normal ageing: a transcranial Doppler study. Neurol 
Res 1990; 12: 187-91. 
6. Babikian VL, Wechsler LR. Transcranial Doppler 
Ultrasonography. 2 ed. Boston, Butterworth-
Heinemann. 1999. 
7. Bland JM, Altman DG. Statistical methods for 
assessing agreement between two methods of clinical 
measurement. Lancet 1986;1:307–10. 
8. Bor-Seng-Shu E, Hirsch R, Teixeira MJ, De Andrade 
AF, Marino R, Jr. Cerebral hemodynamic changes 
gauged by transcranial Doppler ultrasonography in 
patients with posttraumatic brain swelling treated by 
surgical decompression. J Neurosurg 2006; 104: 93-100. 
9. Chung E, Fan L, Degg C, Evans DH. Detection of 
Doppler embolic signals: psychoacoustic considerations. 
Ultrasound Med Biol 2005; 31: 1177-84. 
10.Chung EM, Fan L, Naylor AR, Evans DH. 
Characteristics of Doppler embolic signals observed 
following carotid endarterectomy. Ultrasound Med Biol 
2006; 32: 1011-23. 
11.Crutchfield KE, Razumovsky AY, Tegeler CH, 
Mozayeni BR. Differentiating vascular pathophysio-
logical states by objective analysis of flow dynamics. J 
Neuroimaging 2004; 14: 97 
12.DeWitt LD, Wechsler LR. Transcranial Doppler. 
Stroke 1988; 19:915-21. 
13.Dahl A, Russell D, Nyberg-Hansen R, Rootwelt K. 
A comparison of regional cerebral blood flow and 
middle cerebral artery blood flow velocities: 
simultaneous measurements in healthy subjects. J 
Cereb Blood Flow Metab 1992; 12: 1049-54. 
14.Dreier JP, Sakowitz OW, Harder A, et al. Focal 
laminar cortical MR signal abnormalities after 
subarachnoid hemorrhage. Ann Neurol 2002; 52: 825-9. 
15.Frontera JA, Rundek T, Schmidt JM, et al. 
Cerebrovascular reactivity and vasospasm after 
subarachnoid hemorrhage: a pilot study. Neurology 
2006; 66: 727-9Giller CA, Hatab MR, Giller AM. 
Estimation of vessel flow and diameter during cerebral 
vasospasm using transcranial Doppler indices. 
Neurosurgery 1998; 42: 1076-81 discussion 81-2. 
16.Gosling RG, King DH. Arterial assessment by 
Dopplershift ultrasound. Proc R Soc Med 1974;67:447–9. 
17.Hoffman WH, Pluta RM, Fisher AQ, Wagner MB, 
Yanovski JA. Transcranial Doppler ultrasound 
assessment of intracranial hemodynamics in children 
with diabetic ketoacidosis. J Clin Ultrasound 1995; 23: 
517-23. 
18.Homburg AM, Jakobsen M, Enevoldsen E. 
Transcranial Doppler recordings in raised intracranial 
pressure. Acta Neurol Scand 1993;87:488–93. 
19.Jahromi AS, Cina CS, Liu Y, Clase CM. Sensitivity 
and specificity of color duplex ultrasound measurement 
in the estimation of internal carotid artery stenosis: a 
systematic review and metaanalysis.J Vasc Surg 2005; 
41: 962-72. 
20.Jarus-Dziedzic K, Juniewicz H, Wronski J, et al. The 
relation between cerebral blood flow velocities as 
measured by TCD and the incidence of delayed 
ischemic deficits. A prospective study after 
subarachnoid hemorrhage. Neurol Res 2002; 24: 582-
92.Jorgensen LG. Transcranial Doppler ultrasound for 
cerebral perfusion. Acta Physiol Scand Suppl 1995; 625: 
1-44. 
21.Kirkham FJ, Padayachee TS, Parsons S, Seargeant 
LS, House FR, Gosling RG. Transcranial measurement 
of blood velocities in the basal cerebral arteries using 
pulsed Doppler ultrasound: velocity as an index of flow. 
Ultrasound Med Biol 1986; 12: 15-21. 
22.Larsen FS, Olsen KS, Hansen BA, Paulson OB, 
Knudsen GM. Transcranial Doppler is valid for 
determination of the lower limit of cerebral blood flow 
autoregulation. Stroke 1994; 25: 1985-8. 
23.Lee KY, Sohn YH, Baik JS, Kim GW, Kim JS. 
Arterial pulsatility as an index of cerebral 
microangiopathy in diabetes. Stroke 2000; 31: 1111-5. 
24.Lee JH, Martin NA, Alsina G, et al. 
Hemodynamically significant cerebral vasospasm and 
outcome after head injury: a prospective study. J 
Neurosurg 1997; 87: 221-33. 
25.Lindegaard KF, Nornes H, Bakke SJ, Sorteberg W, 
Nakstad P. Cerebral vasospasm after subarachnoid 
haemorrhage investigated by means of transcranial 
Doppler ultrasound. Acta Neurochir Suppl (Wien) 
1988; 42: 81-4. 
26.Marinoni M, Ginanneschi A, Forleo P, Amaducci L. 
Technical limits in transcranial Doppler recording: 
inadequate acoustic windows. Ultrasound Med Biol 
1997; 23: 1275-7. 
27.Markus HS, Harrison MJ. Microembolic signal 
detection usingultrasound. Stroke 1995; 26: 1517-9. 
28.Markus H, Cullinane M, Reid G. Improved 
automated detection of embolic signals using a novel 
frequency filtering approach. Stroke 1999; 30: 1610-5. 
29.McQuire JC, Sutcliffe JC, Coats TJ. Early changes in 
middle cerebral artery blood flow velocity after head 
injury. J Neurosurg 1998;89:526–32. 
30.Moreno, JA, Mesalles, E, Gener, J, et al. Evaluating 
the outcome of severe head injury with transcranial 
Doppler ultrasonography. Neurosurg Focus 2000; 
8(1):Article 8. 
http://www.neurosurgery.org/focus/jan00/8-1-8.html. 
 
 
 
Romanian Neurosurgery (2011) XVIII 1: 31 – 37          37 
 
 
 
31.Muller M, Voges M, Piepgras U, Schimrigk K. 
Assessment of cerebral vasomotor reactivity by 
transcranial Doppler ultrasound and breath-holding. A 
comparison with acetazolamide as vasodilatory 
stimulus. Stroke 1995; 26: 96-100. 
32.Nadvi SS, du Trevou MD, van Dellen JR, Gouws E. 
The use of transcranial Doppler ultrasonography as a 
method of assessing intracranial pressure in 
hydrocephalic children. Br J Neurosurg 1994;8:573–7. 
33.Pendefunda L.Transcranial Doppler and the 
ethiopathogeny of stroke, Contact int’l, 1991 
34.Pendefunda L.The Cerebral Reactivity, Contact int’l, 
1995 
35.Pendefunda L. Compendiu de semiologie 
neurologica, Junimea 2007 
36.Pendefunda L. Managementul maladiilor 
neurologice, vol I-III, Junimea 2010 
37.Pendefunda L. Compendiu de Patologie neurologica, 
Junimea 2011 
38.Rabinstein AA, Friedman JA, Weigand SD, et al. 
Predictors of cerebral infarction in aneurysmal 
subarachnoid hemorrhage. Stroke 2004; 35: 1862-6. 
39.Romner B, Bellner J, Kongstad P, Sjo¨holm H. 
Elevated transcranial Doppler flow velocities after 
severe head injury: cerebral vasospasm or hyperemia? J 
Neurosurg 1996;85:90–7. 
40.Rothberg CS, Weir B, Overton TR. Treatment of 
subarachnoid hemorrhage with sodium nitroprusside 
and phenylephrine: an experimental study. 
Neurosurgery 1979;5:588–95. 
41.Schreiber SJ, Gottschalk S, Weih M, Villringer A, 
Valdueza JM. Assessment of blood flow velocity and 
diameter of the middle cerebral artery during the 
acetazolamide provocation test by use of transcranial 
Doppler sonography and MR imaging. AJNR Am J 
Neuroradiol 2000; 21: 1207-11. 
42.Sloan MA, Alexandrov AV, Tegeler CH, et al. 
Assessment: transcranial Doppler ultrasonography: 
report of the Therapeutics and Technology Assessment 
Subcommittee of the American Academy of Neurology. 
Neurology 2004; 62: 1468-81 
43.Soehle M, Czosnyka M, Pickard JD, Kirkpatrick PJ. 
Continuous assessment of cerebral autoregulation in 
subarachnoid hemorrhage. 
44.Anesth Analg 2004; 98: 1133-9, table of contents 
Sorteberg W, Lindegaard KF, Rootwelt K, et al. Blood 
velocity and regional blood flow in defined cerebral 
artery systems. Acta Neurochir (Wien) 1989; 97: 47-52. 
45.Sorteberg W. Cerebral Artery Blood Velocity and 
Regional Cerebral Clood Flow in Normal Subjects. In: 
Newell D, Aaslid R, editors. Transcranial Doppler. 
New York, Raven Press. 1992; 57-66. 
46.Soustiel JF, Shik V, Shreiber R, Tavor Y, Goldsher 
D. Basilar vasospasm diagnosis: investigation of a 
modified "Lindegaard Index" based on imaging studies 
and blood velocity measurements of the basilar artery. 
Stroke 2002; 33: 72-7. 
47.Steinmeier R, Laumer R, Bonda´r I, Priem R, 
Fahlbusch R. Cerebral heomdynamics in subarachnoid 
hemorrhage evaluated by transcranial Doppler 
sonography. Part 2. Pulsatility indicies: Normal 
reference values and characteristics in subarachnoid 
hemorrhage. Neurosurgery 1993;33:10–9. 
48.Voldby B, Enevoldsen EM, Jensen FT. 
Cerebrovascular reactivity in patients with ruptured 
intracranial aneurysms. J Neurosurg 1985; 62: 59-67. 
 
